Compare IIIN & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IIIN | VALN |
|---|---|---|
| Founded | 1953 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 574.2M | 582.2M |
| IPO Year | 1994 | 2021 |
| Metric | IIIN | VALN |
|---|---|---|
| Price | $28.87 | $5.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.28 |
| AVG Volume (30 Days) | ★ 150.4K | 20.2K |
| Earning Date | 10-22-2026 | 11-12-2026 |
| Dividend Yield | ★ 0.42% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.51 | N/A |
| Revenue | ★ $739,514,000.00 | N/A |
| Revenue This Year | $8.50 | N/A |
| Revenue Next Year | $5.54 | $87.84 |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | ★ 14.17 | N/A |
| 52 Week Low | $24.35 | $4.75 |
| 52 Week High | $38.45 | $12.18 |
| Indicator | IIIN | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 46.17 | 40.43 |
| Support Level | $28.89 | $5.13 |
| Resistance Level | $29.08 | $5.52 |
| Average True Range (ATR) | 1.02 | 0.18 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 41.53 | 12.12 |
Insteel Industries Inc produces and sells prestressed concrete strand (PC strand) and welded wire reinforcement (WWR). PC strand, a high-strength seven-wire cable, is used to strengthen precast concrete in structures like bridges, parking decks, and buildings, enabling longer spans and slimmer designs. WWR includes engineered structural mesh for primary reinforcement, concrete pipe reinforcement for drainage and sewage systems, and standard WWR for crack control in residential and light commercial construction. The company serves markets in the United States and internationally, with the majority of revenue generated in the United States.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.